BioStock: Stayble Therapeutics’ studies published in leading journal
Spine, the leading scientific journal for research on back pain, has published results from Stayble Therapeutic’s studies with STA363. The results show that STA363 induces connective tissue transformation in the spinal disc. This is the company’s goal in order to be able to treat patients who suffer from chronic disc-related back pain and who are not helped by physiotherapy and painkillers. Inlägget BioStock: Stayble Therapeutics’ studies published in leading journal dök först upp på IPO.
se.